Celcuity CELC Return on equity

Return on equity at other companies

Eli LillyLLY

102.4%+15.7pp

Gilead SciencesGILD

-20.6%-53.8pp

Relay Therapeutics, Inc.RLAY

-36.8%-6.3pp

ImmunomeIMNM

-50.1%-10.8pp

Oric Pharmaceuticals, Inc.ORIC

-42.6%-4.6pp

CytomX TherapeuticsCTMX

-37.8%—

FAQ

What is Celcuity's return on equity?

Celcuity (CELC) reported return on equity of -275.2% in Q1 2026.

How has Celcuity's return on equity changed year-over-year?

Celcuity's return on equity decreased by 138.5% year-over-year, from -115.4% to -275.2%.

What is the long-term trend for Celcuity's return on equity?

Over 5 years (2020 to 2025), Celcuity's return on equity has grown at a 21.8% compound annual growth rate (CAGR), from -61.1% to -163.8%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.